
Benzoyl Peroxide: Reduces inflammatory acne and helps limit antibiotic resistance in acne regimens. Salicylic Acid: Helps unclog acne-prone skin; stronger products treat selected thickened skin lesions.


Choose for inflamed acne; a lower strength is often a practical starting point.
Choose for blackheads and clogged pores; use the strength labelled for that area.
Can you use both?
Both treat acne but together they can over-dry. Use one as a wash and the other as a leave-on, or alternate.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.












Releases reactive oxygen: The active ingredient forms antibacterial oxidizing species. Reduces acne-associated bacteria: Targets Cutibacterium acnes in follicles.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Loosens outer skin cells: Salicylic acid promotes keratin shedding. Helps clear follicular plugs: Its acne role depends on strength and vehicle.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.
Built from where each one usually sits in a routine. Introduce one at a time.
Acne products use 2.5–10% benzoyl peroxide. Trials do not support assuming that the highest percentage is always the best choice.
2.5%
5%
10%
Lower acne strength
A controlled comparison found benefit at this strength; it can be a useful option when irritation limits higher-strength products.
Middle acne strength
Used in washes and leave-on treatments. Contact time and the base formula affect the experience.
Higher acne strength
A labeled higher concentration, but not automatically more effective or more suitable for facial skin.
Choosing a strength: Choose a wash or leave-on product that fits the area and your tolerance. Follow its specific instructions.
Higher strengths: Dryness and irritation can increase with stronger products. Benzoyl peroxide may bleach hair and fabrics at any strength.
Formula matters: A wash and a leave-on gel are not identical doses. Combination acne medicines have their own directions.
The percentage depends on the job: 0.5–2% for OTC acne care, 20–30% in studied office peels, and up to 40% in labeled wart patches. These are different treatments, not steps to work through.
0.5–2%
1.8–3%
5–17%
20–30%
12–40%
Everyday acne care
For blackheads, whiteheads and acne in washes or leave-on products. Follow the product label; dryness or stinging can limit use.
Scalp scale
In labeled treatments for dandruff, seborrheic dermatitis or psoriasis. Helps loosen scale; follow the scalp product’s directions.
Liquid wart removers
For common or plantar warts; 17% is one labeled option. Apply only to the wart, avoiding surrounding healthy skin. Not for facial acne.
Professional office peels
A studied range for clinician-applied peels, including acne treatments. Not for routine home use. Formula, layers and contact time affect the burn risk.
Wart patches and plasters
For common or plantar warts, depending on the label; 40% is a labeled option. Treat the wart only. These are not facial skincare products.
Choosing a strength: Choose for the diagnosis, body area and product type. Facial acne care, scalp products, wart treatments and office peels are not interchangeable.
Higher strengths: High-strength peels can cause burns, scarring and lasting skin-color changes. Wart removers are not for facial or genital warts, irritated or infected skin. Do not self-treat warts with these products if you have diabetes or poor circulation.
Formula matters: The percentage alone does not show how deeply a treatment acts. The base formula, contact time, number of peel layers and whether the product is washed off all matter. Follow the specific label or clinician’s directions.
Approximate windows, not promises.
First few weeksDryness or irritation may occur; worsening is not required for benefit.
First few weeksAssess tolerance and texture; immediate softness can come from the base formula.
4–8 weeksFewer new lesions may become noticeable.
4–8 weeksSubtle changes may appear in some tested products; evidence varies.
8–12 weeksReassess acne control after a consistent course.
8–12 weeksCompare photographs in the same lighting and reassess benefit.
3–6 monthsMaintenance may help if the treatment works and remains comfortable.
3–6 monthsPhotoaging trials often need several months; expect modest rather than dramatic change.
6–12 monthsContinue only if appropriate; scarring or persistent acne warrants reassessment.
6–12 monthsLong-term evidence is limited for many cosmetic actives; continue only if useful.
Dryness, peeling and irritation are common; it can bleach hair and fabrics.
May sting, peel or dry skin; avoid large areas, broken skin and known salicylate allergy without advice.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Seek urgent help for facial swelling, trouble breathing or a severe allergic reaction.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Little is absorbed through skin, and it is generally considered acceptable in pregnancy. Ask the clinician managing your pregnancy.
Over-the-counter strengths on the face are generally considered acceptable, but confirm with the doctor managing your pregnancy. High-strength peels and large body areas are avoided.
On the skin. The finished product delivers benzoyl peroxide in a particular vehicle.
Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. Releases reactive oxygen that reduces acne-associated bacteria and has mild comedolytic effects.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
On the skin. The finished product delivers salicylic acid in a particular vehicle.
Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. Promotes shedding of outer cells and helps clear follicular plugs; concentration and vehicle set its use.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
Choose for inflamed acne; a lower strength is often a practical starting point.
Acne guideline support is strong. Older concentration trials found good results with 2.5%; this does not establish benefit for yeast folliculitis or for ordinary acne products used on rosacea.
Choose for blackheads and clogged pores; use the strength labelled for that area.
Acne guidelines give a conditional recommendation. High-strength wart treatments and 30% peels are distinct interventions; their evidence cannot justify high-strength facial home use.
Sources